These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27572243)

  • 1. Correction to The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver.
    Br J Radiol; 2016 Oct; 89(1066):20150117e. PubMed ID: 27572243
    [No Abstract]   [Full Text] [Related]  

  • 2. The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver.
    Takatsu Y; Akasaka T; Miyati T
    Br J Radiol; 2015 Jun; 88(1050):20150117. PubMed ID: 25833350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: emphasis on image quality and hepatocellular carcinoma detection.
    Lee MH; Kim YK; Park MJ; Hwang J; Kim SH; Lee WJ; Choi D
    J Magn Reson Imaging; 2013 Aug; 38(2):401-10. PubMed ID: 23292998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.
    Balci NC; Befeler AS; Bieneman BK; Fattahi R; Saglam S; Havlioglu N
    Acad Radiol; 2009 Aug; 16(8):963-8. PubMed ID: 19386514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat-suppressed, three-dimensional T1-weighted imaging using high-acceleration parallel acquisition and a dual-echo Dixon technique for gadoxetic acid-enhanced liver MRI at 3 T.
    Yoon JH; Lee JM; Yu MH; Kim EJ; Han JK; Choi BI
    Acta Radiol; 2015 Dec; 56(12):1454-62. PubMed ID: 25480475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat suppression strategies in MR imaging of breast cancer at 3.0 T: comparison of the two-point Dixon technique and the frequency selective inversion method.
    Mikami WK; Kazama T; Sato H; Yokota H; Higashide T; Horikoshi T; Motoori K; Miyazawa Y; Nagashima T; Uno T
    Jpn J Radiol; 2013 Sep; 31(9):615-22. PubMed ID: 23793822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 13. Gadolinium-enhanced liver magnetic resonance imaging using a 2-point Dixon fat-water separation technique: impact upon image quality and lesion detection.
    Rosenkrantz AB; Mannelli L; Kim S; Babb JS
    J Comput Assist Tomogr; 2011; 35(1):96-101. PubMed ID: 21160433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
    AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the modified three-point Dixon technique in obtaining T1-weighted contrast-enhanced fat-saturated images on an open magnet.
    Huegli RW; Tirman PF; Bonel HM; Staedele H; Zaim S; Grigorian M; Genant HK
    Eur Radiol; 2004 Oct; 14(10):1781-6. PubMed ID: 15103501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal flip angle of Gd-EOB-DTPA-enhanced MRI in patients with hepatocellular carcinoma and liver metastasis.
    Okada M; Wakayama T; Yada N; Hyodo T; Numata K; Kagawa Y; Nishiyama D; Miyakoshi K; Murakami T
    Abdom Imaging; 2014 Aug; 39(4):694-701. PubMed ID: 24562726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study.
    Hardie AD; Romano PB
    Magn Reson Imaging; 2010 Feb; 28(2):281-5. PubMed ID: 20071122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.